• home
  • partners
  • contact
  • Uitgaven
  • partners
  • Vacatures
  • Nieuws
  • Agenda
  • Opleidingen
    • Nucleair Radioloog
    • Klinisch fysicus
    • Medisch nucleair werker
    • Ziekenhuisapotheker
    • Radiochemicus
  • Adverteren
  • Redactie
home > Uitgaven > Jun '23. Current status of clinical dosimetry and personalized radionuclide therapy

Jun '23. Current status of clinical dosimetry and personalized radionuclide therapy

Auteur

L.J. de Wit - van der Veen, D.M.V. de Vries-Huizing, M.P.M. Stokkel

Vakblad

TvNG

Editie

2023-02, juni

Thema

Radionuclidentherapie


 

Download nu

De PDF wordt automatisch gedownload. Afhankelijk van uw browser of device opent deze zich automatisch of staat in de downloads van uw browser

  • Inhoudsopgave

The number of patients treated with radionuclide therapy (RNT) has made a giant leap with the approval of targeted Lutetiumlabelled radiopharmaceuticals by the European Medicines Agency (EMA). Though treatments with radioiodine still make up for over 85% of the RNTs in Europe, the scientific breakthroughs are nowadays achieved with new radiolabelled small-molecules and microspheres in various oncological settings.

Hoofdpartner

Business partners

  • Copyright
  • Algemene voorwaarden
  • Disclaimer
  • Privacy
  • Sitemap
  • Colofon

© Kloosterhof Neer BV